Y. Tominaga et al.
FULL PAPER
thesized in 19% yield in a manner similar to that described for the
preparation of 5a and 6a. An analytical sample was recrystallized
from MeOH to give red crystals.
CDCl3): δ = 0.90–1.17 (m, J = 7.1 Hz, 3 H, O-CH2-CH3), 2.15 (s,
3 H, SMe), 3.60–4.16 (m, 2 H, O-CH2-), 6.40–6.70 (m, 1 H, pyridyl-
H), 7.20–7.80 (m, 7 H, phenyl-H, pyridyl-H), 8.12 (d, J = 10.2 Hz,
1 H, pyridyl-H), 14.02 (br. s, 1 H, NH) ppm. 13C NMR (100 MHz,
CDCl3): δ = 14.24, 15.14, 16.28, 59.66, 81.43, 110.62, 110.78,
111.77, 114.15, 114.62, 117.81, 118.76, 127.69, 127.97, 128.74,
129.01, 133.16, 133.31, 133.92, 137.97, 139.94, 140.85, 150.92,
166.24, 145.00, 166.51, 173.84, 175.86 ppm. MS: m/z (%) = 403 (5)
[M + 1]+, 402 (19) [M]+, 261 (100), 260 (55), 215 (63), 77 (34).
C19H18N2O4S2 (402.4893): calcd. C 56.70, H 4.51, N 6.96; found C
56.69, H 4.54, N 6.86.
Methyl 4-Imino-3-tolylsulfonyl-4H-quinolizine-1-carboxylate (4d):
M.p. 216–218 °C. IR (KBr): ν = 3343 (NH), 1691 (CO), 1618, 1492,
˜
1141, 781 cm–1. UV (EtOH): λ (logε) = 436.0 (3.99), 365.0 (4.03),
270.5 (4.19) nm. Fluorescence (solid): λEx = 340 nm; λEm = 533 nm,
RI = 1.17. Fluorescence (CH2Cl2): λEx = 280 nm; λEm = 511 nm;
RI = 0.47. 1H NMR (300 MHz, CDCl3): δ = 2.39 (s, 3 H, Me),
3.89 (s, 3 H, OMe), 7.18 (m, 1 H, 7-H), 7.30 (d, J = 8.4 Hz, 2 H,
phenyl-H), 7.80 (m, 1 H, 8-H), 7.84 (d, J = 8.4 Hz, 2 H, phenyl-
H), 8.60 (br. s, 1 H, NH), 8.85 (s, 1 H, 2-H), 9.30 (d, J = 9.0 Hz, 1
H, 6-H), 9.67 (d, J = 7.8 Hz, 1 H, 9-H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 21.55, 51.79, 97.15, 113.19, 116.98, 123.94, 127.17,
129.85, 130.94, 137.51, 137.74, 139.21, 144.29, 147.81, 151.62,
165.15 ppm. MS: m/z (%) = 357 (11) [M + 1]+, 356 (51) [M]+, 291
(100), 201 (32), 169 (46). C18H16N2O4S2 (388.46): calcd. C 60.66,
H 4.53, N 7.86; found C 60.75, H 4.35, N 7.88.
Reaction of 1b with 2c: Compound 4f (0.89 g, 2.4 mmol) was syn-
thesized in 48% yield from 2c (1.65 g, 10.0 mmol) and 1b (1.44 g,
5.0 mmol) in a manner similar to that described for the preparation
of 4c. An analytical sample was recrystallized from EtOH to give
yellow needles. Compounds 5d and 6d (0.92 g, 2.2 mmol) was syn-
thesized in 44% yield in manner similar to that described for the
preparation of 5a and 6a. An analytical sample was recrystallized
from MeOH to give red crystals.
Methyl
(2Z,3E)-4-Cyano-3-methylsulfanyl-4-tolylsulfonyl-2-(1H-
pyrid-2-ylidene)butenoate (5b and 6b): M.p. 165–168 °C. IR (KBr):
˜
Ethyl 4-Imino-3-tolylsulfonyl-4H-quinolizine-1-carboxylate (4f):
ν = 2201 (CN), 1618, 1590, 1283 1151, 584 cm–1. UV (EtOH): λ
M.p. 177–178 °C. IR (KBr): ν = 3302 (NH), 1761 (CO), 1704 (CO),
˜
(logε) = 393.0 (3.59), 302.5 (4.09) nm. 1H NMR (300 MHz,
CDCl3): δ = 2.14 (s, 3 H, Me), 2.38 (s, 3H/2, SMe), 2.48 (s, 3H/2,
SMe), 3.41 (s 3H/2, OMe), 3.56 (s, 3H/2, OMe), 6.40–6.60 (m, 1
H, pyridyl-H), 7.19 (m, 1 H, pyridyl-H), 7.38 (m, 2 H, phenyl-H),
7.48 (m, 2 H, phenyl-H), 7.61 (d, J = 7.8 Hz, 1 H, pyridyl-H), 7.97
(d, J = 8.1 Hz, 1 H, pyridyl-H), 14.00 (br. s, 1 H, NH) ppm. 13C
NMR (100 MHz, CDCl3): δ = 15.14, 16.27, 21.54, 21.73, 50.72,
51.10, 81.40, 110.57, 110.85, 111.94, 114.12, 114.73, 117.80, 118.77,
127.77, 128.10, 129.35, 129.58, 133.36, 133.93, 136.95, 137.82,
137.97, 139.06, 144.22, 145.01, 150.86, 151.00, 166.59, 166.97,
173.04, 174.86 ppm. MS: m/z (%) = 403 (5) [M + 1]+, 402 (21)
[M]+, 247 (100), 215 (32), 200 (83), 168 (25), 91 (26). C19H18N2O4S2
(402.4893): calcd. C 56.70, H 4.51, N 6.96; found C 56.71, H 4.48,
N 6.79.
1615, 1513 cm–1. UV (EtOH): λ (logε) = 435.5 (3.12), 364.5 (3.17),
271.5 (3.34) nm. Fluorescence (solid): λEx = 332 nm; λEm = 536 nm,
RI = 0.62. Fluorescence (CH2Cl2): λEx = 284 nm; λEm = 519 nm;
1
RI = 0.25. H NMR (300 MHz, CDCl3): δ = 1.42 (t, J = 7.1 Hz,
3 H, O-CH2-CH3), 2.39 (s, 3 H, Me), 4.36 (q, J = 7.1 Hz, 2 H, O-
CH2-), 7.17 (m, 1 H, 7-H), 7.30 (d, J = 7.9 Hz, 2 H, phenyl-H),
7.77 (m, 1 H, 8-H), 7.84 (d, J = 7.9 Hz, 2 H, phenyl-H), 8.56 (br.
s, 1 H, NH), 8.84 (s, 1 H, 2-H), 9.31 (d, J = 9.0 Hz, 1 H, 6-H),
9.66 (d, J = 6.6 Hz, 1 H, 9-H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 14.48, 21.56, 60.73, 97.52, 113.09, 116.91, 124.00, 127.19,
129.85, 130.94, 137.38, 137.73, 139.16, 144.28, 147.82, 151.66,
164.76 ppm. MS: m/z (%) = 371 (9) [M + 1]+, 370 (40) [M]+, 306
(23), 305 (100), 277 (28), 225 (25). C19H18N2O4S (370.4233): calcd.
C 61.61, H 4.90, N 7.56; found C 61.63, H 4.93, N 7.42.
Reaction of 1a with 2c: Compound 4e (0.33 g, 0.9 mmol) was syn-
thesized in 46% yield from 2c (0.33 g, 2.0 mmol) and 1a (0.86 g,
3.0 mmol) in a manner similar to that described for the preparation
of 4c. An analytical sample was recrystallized from EtOH to give
yellow needles. Compounds 5c and 6c (0.35 g, 0.9 mmol) were syn-
thesized in 44% yield in a manner similar to that described for the
preparation of 5a and 6a. An analytical sample was recrystallized
from MeOH to give red crystals.
Ethyl
(2Z,3E)-4-Cyano-3-methylsulfanyl-4-tolylsulfonyl-2-(1H-
pyrid-2-ylidene)butenoate (5d and 6d): M.p. 132–135 °C. IR (KBr):
ν = 2207 (CN), 1650 (CO), 1615, 1585, 1267, 1150, 588 cm–1. UV
˜
(EtOH): λ (logε) = 392.0 (3.69), 304.0 (4.19) nm. 1H NMR
(300 MHz, CDCl3): δ = 0.98 (t, J = 7.1 Hz, 3H/2, O-CH2-CH3),
1.10 (t, J = 7.1 Hz, 3H/2, O-CH2-CH3), 2.15 (s, 3 H, Me), 2.39 (s,
3 H, Me), 3.70 (m, 2H/2, O-CH2-), 4.0 (m, 2H/2, O-CH2-), 6.43–
6.65 (m, 1 H, pyridyl-H), 7.20 (m, 1 H, pyridyl-H), 7.37 (m, 2 H,
phenyl-H), 7.46 (m, 2 H, phenyl-H), 7.62 (m, 1 H, pyridyl-H), 7.97
(m, 1 H, pyridyl-H), 14.00 (br. s, 1 H, NH) ppm. 13C NMR
(100 MHz, CDCl3): δ = 13.91, 14.12, 15.04, 16.20, 21.45, 21.60,
59.54, 61.83, 81.32, 110.46, 110.75, 111.94, 114.12, 114.67, 117.70,
118.62, 126.82, 127.67, 127.98, 129.29, 129.56, 133.40, 133.95,
136.42, 136.94, 137.84, 138.96, 144.18, 145.00, 150.85, 166.22,
166.45, 173.29, 174.31 ppm. MS: m/z (%) = 416 (3) [M]+, 260 (100),
215 (72), 214 (38), 188 (20), 139 (30), 91 (27). C20H20N2O4S2
(416.5159): calcd. C 57.67, H 4.84, N 6.73; found C 57.34, H 4.82,
N 6.59.
Ethyl 4-Imino-3-phenylsulfonyl-4H-quinolizine-1-carboxylate (4e):
M.p. 152–155 °C. IR (KBr): ν = 3356 (NH), 1694 (CO), 1639, 1618,
˜
1489, 578 cm–1. UV (EtOH): λ (logε) = 437.0 (4.03), 364.5 (4.06),
272.0 (4.19) nm. Fluorescence (solid): λEx = 339 nm; λEm = 528 nm;
RI = 1.44. Fluorescence (CH2Cl2): λEx = 284 nm; λEm = 511 nm;
1
RI = 0.47. H NMR (300 MHz, CDCl3): δ = 1.43 (t, J = 7.1 Hz,
3 H, O-CH2-CH3), 4.36 (q, J = 7.1 Hz, 2 H, O-CH2-), 7.17 (m, 1
H, 7-H), 7.45–7.62 (m, 3 H, phenyl-H), 7.79 (m, 1 H, 8-H), 7.96
(m, 2 H, phenyl-H), 8.61 (br. s, 1 H, NH), 8.86 (s, 1 H, 2-H), 9.32
(d, J = 9.0 Hz, 1 H, 6-H), 9.67 (d, J = 6.9 Hz, 1 H, 9-H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 14.47, 60.76, 97.60, 112.60, 117.04,
124.03, 127.08, 129.21, 130.99, 133.27, 137.54, 139.43, 140.75,
147.88, 151.64, 164.70 ppm. MS: m/z (%) = 357 (14) [M + 1]+, 356
(65) [M]+, 292 (20), 291 (95), 133 (100), 105 (45). C18H16N2O4S
(356.3967): calcd. C 60.66, H 4.53, N 7.86; found C 60.54, H 4.38,
N 7.89.
X-ray Crystallographic Studies: The reflection data were collected
at 23 Ϯ1 °C with a Rigaku Mercury area detector with graphite
monochromated Mo-Kα radiation. All calculations were performed
by using the CrystalStructure crystallographic software package.[13]
CCDC-736921 (for 4a), -736922 (for 4c), and -725724 (for 5b) con-
Ethyl
(2Z,3E)-4-Cyano-3-methylsulfanyl-4-phenylsulfonyl-2-(1H- tain the supplementary crystallographic data for this paper. These
pyrid-2-ylidene)butenoate (5c and 6c): M.p. 143–146 °C. IR (KBr): data can be obtained free of charge from The Cambridge Crystallo-
1
ν = 2204 (CN), 1638 (CO), 1582, 1277 cm–1. H NMR (300 MHz, graphic Data Centre via www.ccdc.cam.au.uk/data_request/cif.
˜
5852
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 5847–5853